Kaleido Biosciences, Inc.
USD0.00
+0.00 (+0.00%)
CEO
Mark A. Wingertzahn
IPO Date
2019-02-28
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.20
Market Cap
$0.00B
Volume
0.00M
| -3.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -173.9% | -103.3% | 0.42 | 7.06 | -1.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -106.1% | -72.4% | 0.26 | 6.75 | -6.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 63.1% | -89.6% | -0.34 | 7.41 | -11.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 57.3% | -194.1% | -0.29 | 3.61 | -32.9 |
| -2.6 |
| 30 Jun 2021 | Q2 | 100.0% | -11655.5% | -48.9% | -29.2% | 0.42 | 6.08 | -3.2 |
| 31 Mar 2021 | Q1 | 100.0% | -7994.9% | -33.1% | -22.6% | 0.30 | 7.38 | -3.4 |
| 31 Dec 2020 | Q4 | 100.0% | -8004.1% | -94.9% | -32.8% | 1.03 | 2.77 | -4.2 |
| 30 Sept 2020 | Q3 | 100.0% | -4799.0% | -64.4% | -31.6% | 0.58 | 4.46 | -4.3 |
| 30 Jun 2020 | Q2 | 100.0% | -7568.8% | -36.9% | -21.8% | 0.40 | 6.72 | -3.1 |
| 31 Mar 2020 | Q1 | 0.0% | 0.0% | -58.2% | -29.3% | 0.61 | 6.18 | -2.4 |
| 31 Dec 2019 | Q4 | 0.0% | 0.0% | -39.9% | -23.7% | 0.42 | 7.06 | -1.9 |
| 30 Sept 2019 | Q3 | 0.0% | 0.0% | -33.3% | -24.1% | 0.23 | 8.11 | -2.6 |